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We have constructed transgenic tobacco plants (Mlx2-FCP2IFN plants) expressing viral RNA replication genes of brome mosaic virus (BMV) 
and BMV RNA3 derivative (FCPZIFN) carrying the human gamma interferon (IFN-J) gene. In Mlx2-FCP2IFN plants the RNA3 derivative 
expressed from the integrated cDNA was replicated and subgenomic RNA (i.e. mRNA of IFN-)I) was produced by BMV replicase. The 
accumulation level of the mRNA of IFN-)I was approximately 5-fold higher than that by the cauliflower mosaic virus (CaMV) 35s RNA promoter. 
In addition IFN-y accumulated in Mlx2-FCP2IFN plants. 
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1. INTRODUCTION RNA4, which is synthesized from the negative strand of 
RNA3 [l I]. 
Recently transgenic plants have been used for pro- 
ducing desired proteins such as nuropeptides [l], blood 
factors [2] and antibody [3]. However, yields of those 
protein products in transgenic plants are often disap- 
pointingly low. This may be due to lack of a strong 
promoter suitable for high expression of foreign genes 
in plant cells. It seems that one of the key determinants 
for the success in agricultural production of a valuable 
foreign protein is how to level up the expression of 
foreign genes in transgenic plants. 
To develop a more efficient system for high-level syn- 
thesis of foreign proteins in plants, an RNA virus repli- 
cation system based on RNA-dependent RNA synthesis 
is very attractive since the replication system at RNA 
level can apply to amplification of mRNA for a foreign 
gene in transgenic plant cells and may surmount several 
impediments encountered in the production of foreign 
protein in the DNA-directed transcription system. In 
this paper we present a new system (an in vivo mRNA 
amplification system) in which DNA-directed mRNA 
can be amplified in vivo by viral replicase expressed 
from the integrated cDNAs in transgenic plants. 
Recently, we have demonstrated that transgenic to- 
bacco plants (M 1x2 plants) expressing BMV RNA rep- 
lication genes la and 2a under control of the CaMV 35s 
RNA promoter support RNA-dependent replication of 
RNA 3 in transfected protoplasts [12]. In this paper we 
introduced a cDNA of BMV RNA 3 derivative 
(FCP2IFN) [13] carrying the human gamma interferon 
(IFN-y) gene linked to the 35s promoter into the chro- 
mosomal DNA of Mlx2 plants. We show the replica- 
tion of FCP2IFN and production of subgenomic 
mRNA of IFN-y in Mlx2-FCP2IFN plants. 
2. MATERIALS AND METHODS 
2.1. Plasmid construction 
We used brome mosaic virus (BMV), a positive sense 
single-stranded RNA plant virus, The genome of BMV 
is divided among three S-capped separate RNAs (desig- 
nated RNAs 1,2 and 3) [4]. RNA 1 and RNA 2 encode 
the helicase-like la protein and the polymerase-like 2a 
protein, respectively, which are required for viral RNA 
replication [5-81. BMV RNA3 encodes the 3a protein, 
which is thought to be involved in cell-to-cell movement 
of viruses in plants [9,10], and the coat protein gene. The 
coat protein is translated from a subgenomic mRNA, 
A plasmid pARK22 (kindly provided from Dr. H. Anzai) contain- 
ing a bar gene was digested with PsrI, made blnnt with T4 DNA 
polymerase and self-ligated to remove the PstI site, creating 
pARK22(-Pst). The pARK22(-Pst) was cut with EcoRI and made 
blunt with T4 DNA polymerase, and then ligated with PstI linkers, 
creating pARK22(E-P). The binary vector pBICP35 [14] containing 
the 35s promoter and termination signal was partially cut with PstI 
and digested with HindIII. The resulting plasmid was ligated with the 
PstI-HindIII-cut fragment of pARK22(E-P), creating pBICBP35. 
The fragment of SnaBI-EcoRI-cut pBB3 [14] (i.e. full-length cDNA 
of RNA 3) was inserted into St&EcoRI-cut pBICBP35, creating 
pBICBPBR3. The fragment of XbaI-EcoRI-cut fragment of 
pBTCP2IFN was inserted into XbaI-EcoRI-cut pBICBPBR3, creat- 
ing pBICBPCP2IFN. 
2.2. Plant transformation 
*Corresponding author. Fax: (81) (75) 753 6146. 
pBICBPCP2IFN was mobilized into Agrobacterium tumefaciens 
(strain LBA4404) using E. coli HBlOl harboring pRK2013, as de- 
scribed [15]. Transformation of N. tabacum cv. Petit Habana (SRI) 
was carried out using the leaf disc transformation method [16]. Trans- 
formed shoots and roots were selected by propagation on medium 
containing both kanamycin and bialaphos and eventually transferred 
to a glasshouse for production of mature plants. 
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2.3. RNA isolation and Northern blot analysis 
RNA was isolated from tobacco plants as described [13]. The RNA 
was denatured in formaldehyde/formamide and fractionated on a 
1.5% agarose gel containing 1.8% formaldehyde and transferred to a 
BIODYNE membrane. Detection of positive-sense viral RNA was by 
a “P-labeled SP6 transcript from a subclone containing the 200-base 
Hind111 (nt 1914 jEcoRI3’-terminal fragment of BMV RNA 3 cDNA 
which is conserved among all BMV RNAs. To detect negative-sense 
viral RNA we used 32P-labeled positive-sense RNA of the 200-base 
3’-terminal fragment. 
2.4. Protein analysis 
Total protein was extracted from transgenic plants with Laemmli 
buffer [17], and separated on a 15% polyacrylamide gel containing 
0.1% SDS. Western blot analysis was carried out as described [13]. 
Electrophoresed proteins were transferred to an Immobilon-P transfer 
membrane (Millipore) and probed with antibody against IFN-y. 
3. RESULTS 
3.1. Production of transgenic tobacco plants expressing 
both BMV replicase and FCP2IFN 
Transgenic tobacco plants (M 1 x2 plants) [ 121 express- 
ing BMV replication gene la and 2a proteins were 
transformed with an Agrobacterium binary vector (des- 
ignated pBICBPCP2IFN) which contains full-length 
cDNA of FCP2IFN [13] linked to the CaMV 35s RNA 
promoter and a bar gene as a selection marker that 
confers resistance to bialaphos (Fig. 1). FCP2IFN is a 
BMV RNA 3 derivative having the IFN-y gene replac- 
ing the truncated coat protein (CP2) gene [ 181 in RNA3. 
FCP2IFN is able to replicate and produce subgenomic 
mRNA of IFN-)I in tobacco protoplasts when coinocu- 
lated with BMV RNA1 and RNA2 transcripts [13]. 
Expression of BMV replicase and FCP2IFN was 
tested as described below. Transgenic tobacco plants 
resistant to both bialaphos and kanamycin were ob- 
tained. Integration of cDNAs was conBrmed by South- 
ern blot analysis. Transgenic tobacco plants expressing 
both BMV replicase and FCP2IFN were designated 
Mlx2-FCP2IFN plants. Fr progenies with a different 
pattern of gene expression were obtained by self-polli- 
nation of primary transformants, since both BMV repli- 
cation genes and cDNA of FCP2IFN in & plants are 
not homozygous. In this study we used three kinds of 
F, progenies expressing replicase alone (Mlx2 plants), 
FCP2IFN alone (designated FCP2IFN plants) and 
both BMV replicase and FCP2IFN (Mlx2-FCP2IFN 
plants). 
3.2. Replication of FCP2IFN and production of sub- 
genomic mRNA in transgenic tobacco plants ex- 
pressing both BMV replicase and FCP2IFN 
The expression and replication of FCP2IFN and the 
production of subgenomic mRNA in Mlx2-FCP2IFN 
plants were analyzed by Northern blotting with strand- 
specific probes for the conserved 3’-terminal non-coding 
sequence of the wild-type BMV RNAs (Note that these 
3’-terminal sequences are not present in viral replicase 
transcripts expressed in Mlx2 plants). The use of a 
positive strand-specific probe did not give any detecta- 
ble bands in Mlx2 plants (Fig. 2A, lane 2). However, 
a band with mobility slower than that of FCP2IFN 
observed in FCP2IFN-infected tobacco protoplasts was 
detected in both Mlx2-FCP2IFN and FCPUFN plants 
(Fig. 2A, lanes 3 and 4). These bands must be the 35s 
promoter-driven transcripts with non-viral and polyad- 
enylated sequences at the 3’ end. In addition to the 35s 
promoter-driven transcripts, in Mlx2-FCP2IFN plants 
two more bands with the same mobility as those of 
FCP2IFN and its subgenomic RNA were observed in 
FCP2IFN-infected tobacco protoplasts (Fig. 2A, lane 
4). The replication of FCP2IFN and transcription of 
subgenomic RNA from FCP2IFN by viral replicase in 
Mlx2-FCP2IFN plants was cor&rned by the presence 
of the negative-strand RNA which comigrated with the 
negative-strand FCP2IFN in FCP2IFN-infected to- 
bacco protoplasts (Fig. 2B). These results indicate that 
in Mlx2-FCP2IFN plants BMV replicase initiated neg- 
ative strand synthesis at a correct site and eliminates the 
extra nucleotides at their 3’ end and leads to replication 
of authentic FCP2IFN and transcription of subgenomic 
mRNA from the negative-strand FCP2IFN [14,19]. The 
accumulation level of the subgenomic RNA was ap- 
proximately 5-fold larger than that of the 35Sdriven 
FCP2IFN and was approximately 0.05% of the total 
extracted RNA (data not shown). 
3.3. Accumulation of human gamma interferon in MIX?- 
FCP2 IFN plants 
Immunological analysis using antibody against 
FCPPIFN H 3a I-$ FN-Y h 
/5 P35sI Bar ITN~~HP~ssI 
Fig. 1. Schematic representation of the binary vector for RNA 3 derivative carrying gamma interferon gene (FCP2IFN). l , cap structure; 3a, 
3a gene; ., T-DNA border sequence; P,,, cauliflower mosaic virus 35s promoter; T,,,,, 35s terminator; Bar, bar gene; T,,, nopaline synthase 
terminator. The shadowed box indicates 24 nucleotides coding for the N-terminal amino acids of a full-length coat protein. 
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IFN-y revealed that IFN-y with M,s of approximately 
23 kDa and 18 kDa was detected in total protein extract 
from Mlx2-FCP2IFN plants but not in protein from 
either Mlx2 or FCP2IFN plants (Fig. 3). These 23 kDa 
and 18 kDa proteins may be glycosylated and non- 
glycosylated IFN-)I, respectively [131. 
4. DISCUSSION 
The results presented here show that DNA-directed 
RNA transcripts were amplified and subgenomic 
mRNAs from the transcripts were produced by viral 
replicase expressed in transgenic plants. This mRNA 
amplification system holds potentiality to overcome low 
production of mRNA by the DNA-directed transcrip- 
tion system. Furthermore, this system is more suitable 
for mass production of foreign proteins in plants than 
a direct viral system in which foreign proteins are pro- 
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Fig. 2. Northern blot analysis of replication of FCP2IFN in transgenic 
tobacco plants expressing BMV rep&se. Total RNAs were extracted 
from non-transgenic tobacco plants (lane l), Mlx2 plants (lane 2), 
FCP2IFN plants (lane 3), Mlx2-FCP2IFN plants (lane 4) and to- 
bacco protoplasts inoculated with FCP21FN together with RNA 1 
and RNA 2 (lane 5). Lane 6 contains 500 pg of in vitro synthesized 
FCPZIFN and its subgenomic mRNA of IFN-y. The RNA (5 pg in 
lane 1-4A, 1.25 pg in lane 5A, 10 pg in lane 1-4B, 2.5 pg in lane 5B) 
was separated on a 1.5% agarose gel containing formaldehyde, and 
transferred to a nylon membrane. (A) Positive-sense RNA was de- 
tected by a ‘2P-labeled in vitro transcript complementary to the con- 
served 3’ terminal 200 bases of FCPZIFN and wild-type BMV genomic 
RNAs.(B) Negative-sense RNA was detected by a 32P-labeled positive 
sense in vitro transcript of the conserved 3’ 200 base of FCP2IFN and 
wild-type BMV genomic RNAs. The positions of viral RNAs are 
indicat& in the margin. l indicates the 35s promoter-d~ven tran- 
scripts of FCPZIFN. 
Fig. 3. Immunological analysis of gamma interferon produced in 
transgenic tobacco plants. Total proteins were extracted from non- 
transgenic tobacco plants (lane l), Mlx2 plants (lane 2), FCPZIFN 
plants (lane 3) and Mlx2-FCPZIFN plants (lane 4). and separated on 
15% SDS-PAGE. XFN-y was identifi~ by ~m~oblotting. The posi- 
tion of IFN-r is indicated in the margin. 
duced by inoculating plants with a genetically engi- 
neered virus carrying foreign genes, These mutant vi- 
ruses having foreign genes by gene replacement or inser- 
tion in viral genome have poor or no ability to infect a 
whole plant [8,20-221. Even though the recominant 
virus replicates in a whole plant [23-2.51, the infection 
procedure will be an obstacle to scale up this system to 
a farm level. 
The expression level of mRNA in our in vivo mRNA 
amplification system is approximately fivefold greater than 
that of the CaMV 35s promoter-driven transcripts, 
however this system has many potentialities for further 
improvement. In this research tobacco plants (non-host 
plant of BMV) were used for the easiness in obtaining 
transgenic plants. The use of host plants of BMV in the 
system will improve the efficiency of mRNA amplifica- 
tion, since the replication level of BMV in host plants 
such as barley or Ncotiana benthamiana ismuch higher 
than that in non-host tobacco plants [26]. 
The use of a cDNA cassette containing self-cleavage 
sequence at the 3’ end of FCP2IFN will improve the 
template activity of foreign gene transcripts to viral 
replicase compared with the CaMV 3% driven- 
FCP2IFN which has heterologous sequences at the 
3’ end [19]. 
The amplification of mRNA can be controlled at the 
transcription level in either the foreign gene or viral 
replication genes if these genes are joined to various 
promoters instead of the constitutive CaMV 35s pro- 
moter. Inducible and organ-specific promoters will 
open the way to produce the desired proteins at the 
desired time and desired tissues. 
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